Skip to content

ixX pharma

Active Public limited companyfounded 2005active for 21 yearsBorsbeeksebrug 34, 2600 AntwerpKBO/BCE: BE 0873.490.740 subsidiary of

Lifetime

20 annual accounts with figures on one time axis
peak of €4.7m in 2020
-not published
lowest -€277,642 in 2006
€1.7m▲ 40.3%
peak of €6.9m in 2025
€6.9m▲ 10.2%
€4.3m▲ 8.4%
peak of 27.4 FTE in 2024
26.3 FTE▼ 4.0%
Board11 names since 2011
2 directors and 1 other
Owners3 names in the annual accounts
100% and 1 other
Documentsfilings and deeds
31-08-202631 days late
2025financial year
Result from €1.2m to €1.7mRegistered office moved from Sint-Niklaas to Antwerp 24-07 resigns as day-to-day manager 19-05Dividend €1.1mInvestments €1.2m

Key points

from the 2025 annual accounts

Equity

€6.9m ▲ 10.2%
6.32024+1.7Profit-1.1Dividend6.92025

ixX pharma paid out €1.1m in dividends. That is 62% of the 2025 profit.

Staff

24 employees on 31-12-2025
43202167202284202314620248162025

In 2025, 8 employees joined and 16 left.

Payment terms

52 days to suppliers
Suppliers
107 to 52
Customers
85 to 37

ixX pharma pays its suppliers 55 days earlier than in 2024. Customers pay 48 days earlier.

Board

2 joined · 1 left

Board changed. Latest change 30-04-2026 · 2 in office.

2025 accounts filed 31 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as ixX pharma has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for ixX pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director,
Daily manager
Daily manager
Director
Auditor,
  • 100%score equity -€13.3m (2025) · annual accounts 2025
  • consolidatesannual accounts 2025
Board & ownership

Recent changes

Merger: ixX PHARMA takes over BIOCYTE BENELUX Board meeting of 17-07-2026 · Gazette deed
Merger proposal: IXX PHARMA takes over BIOCYTE BENELUX Board meeting of 27-05-2026 · Gazette deed
2 directors appointed, 1 resignation resigns as day-to-day manager · (day-to-day manager) and (day-to-day manager) appointed · Board meeting of 29-04-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0873490740
All 46 events

Comparable companies

same main activity, similar in size and age
Company
ixX pharma Antwerp €11.6m 18.9% 61.4% 26.3
INNOMEDIQ Heist-op-den-Berg €15.3m 24.2% 67.1% 25.8
Flen Health Pharma Kontich €12.7m 18.6% 92.9% 29.9
Alfasigma Belgium Mechelen €13.7m 7.1% 23.3% 40.9
EDWARDS LIFESCIENCES BELGIUM Vilvoorde €14.0m 6.4% 53.6% 29
KEYPHARM Oostkamp €14.9m 13.2% 54.8% 18
SARTORIUS STEDIM BELGIUM Woluwe-Saint-Lambert €14.0m 43.8% 21.2% 32.5
-10%0%10%20%€20m€200m€2bn€20bnixX pharmaEBIT margin

Grey: the largest companies of the sector (wholesale trade (NACE 46)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as ixX pharma: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €6.8m and €16m, founded between 2000 and 2009.

Official details

Source: KBO
Status
Active since 26-04-2005Normal situation
Registered office
101 active companies are registered at this address7 started in the 12 months before. Source: KBO register, as of 19 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Joint committee
207White-collar workers in the chemical industry · annual accounts 2025
Establishment unit
2.147.131.0282600 Antwerp, registered on 26-04-2005
Financial year end
31 December
Peppol
Reachable since 30-07-2025
Company details

Annual accounts 2025

€11.3m▲ 9.5%
Employeeson 31-12-2025
24▼ 25.0%
Filing
Filed on 31-08-2026
Financials

Insights on ixX pharma

ixX pharma has existed since 2005. In 2009 the gross margin rose from €615,666 to €1.3m.

holds all the shares. In December 2021, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ixX pharma

What is the company number of ixX pharma?
The company number of ixX pharma is 0873.490.740. The VAT number is the same number with BE in front: BE 0873.490.740.
Where is ixX pharma based?
The registered office is at Borsbeeksebrug 34, 2600 Antwerp.Company details
What does ixX pharma do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of ixX pharma?
ixX pharma is a public limited company (NV).
When was ixX pharma founded?
ixX pharma was founded on 26-04-2005.
Is ixX pharma still active?
Yes, ixX pharma is an active enterprise in the KBO register.
How many employees does ixX pharma have?
ixX pharma had an average of 26.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does ixX pharma fall under?
In its 2025 annual accounts, ixX pharma states joint committee 207 (White-collar workers in the chemical industry).
What is the turnover of ixX pharma?
The turnover of ixX pharma was €11.6m in financial year 2025, according to the filed annual accounts.
Is ixX pharma profitable?
In financial year 2025, ixX pharma made a profit of €1.7m.
Where can I find the annual accounts of ixX pharma?
ixX pharma filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ixX pharma due?
ixX pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.